STEINMAN LAWRENCE 4
4 · 180 Life Sciences Corp. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
STEINMAN LAWRENCE
Director
Transactions
- Purchase
Common Stock
2023-06-01$1.23/sh+18,000$22,068→ 48,129 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.